ARIAD Reports Second Quarter and First Half 2016 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/4/2026
- Nasdaq futures underpinned by strong AI forecasts; focus on earnings, data
- Fed's Williams says rate hikes possible if inflation persists
- Citi says buy these 3 chip stocks on pullback
- Microsoft joins, Broadcom exits Goldman's top-stocks list
- Deutsche Bank raises S&P 500 earnings estimates on the back of the solid Q2 beats
- After-Hours Stock Movers: PLTR, SNAP, ON, ICHR, WGS, WHR
- After-Hours Stock Movers: AAPL, AMZN, COIN, RBLX, RDDT, AXTI, FND, WU, GDDY
- After-Hours Stock Movers: META, MSFT, CMG, SBUX, CVNA, LRCX, FTNT, QCOM, TDOC
- After-Hours Stock Movers: F, BE, STX, WDC, KLAC, SWKS, NXPI, CSGP, ENPH
- After-Hours Stock Movers: FFIV, CDNS, APLD, RMBS, ESI, SANM
ARIAD Pharma (ARIA) Tops Q2 EPS Views
July 28, 2016 7:36 AM EDTARIAD Pharma (NASDAQ: ARIA) reported Q2 EPS of $0.59, $0.70 better than the analyst estimate of ($0.11). Revenue for the quarter came in at $65.3 million versus the consensus estimate of $60.64 million.
For earnings history and earnings-related data on ARIAD Pharma (ARIA) click here.
... More